Results 231 to 240 of about 22,351 (243)

Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use

Multiple Sclerosis Journal, 2015
Celia Chen
exaly  

The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis

CNS Drugs, 2015
Samuel F Hunter, James D Bowen, Anthony T Reder   +2 more
exaly  

Clinical activity after fingolimod cessation: disease reactivation or rebound?

European Journal of Neurology, 2018
Jessica Frau, Maria Pia Sormani, Alessio Signori   +2 more
exaly  

Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies

Multiple Sclerosis Journal, 2016
Damiano Baroncini, A Ghezzi, Bruno Colombo   +2 more
exaly  

Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy

Multiple Sclerosis Journal, 2014
Ludwig Kappos, Paul O’Connor, François Mercier   +2 more
exaly  

Vagomimetic Effects of Fingolimod: Physiology and Clinical Implications

CNS Neuroscience and Therapeutics, 2014
Gianluca Botto
exaly  

Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage

Experimental Neurology, 2013
William B Rolland, Tim Lekic, Paul R Krafft   +2 more
exaly  

Fingolimod

Reactions Weekly, 2018
openaire   +1 more source

Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis

Drugs, 2014
Mark Sanford, Sanford Mark
exaly  

Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage

Neuroscience Bulletin, 2015
Ye Gong, Chun-Sheng Yang, Kristofer Wood   +2 more
exaly